Uflex
Uflex Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Aseptic packaging volumes expected around 8.5 billion packs in FY26, with potential upside (Page 5, 9). - Significant improvement in volumes anticipated from FY27 onwards after commissioning new Egypt aseptic plant and full utilization of expanded India facility (Page 9). - Incremental revenue from three new projects expected to be Rs. EBITDA for FY'26 is expected to be around Rs.
From Uflex's Q3 FY26 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Aseptic packaging volumes expected around 8.5 billion packs in FY26, with potential upside (Page 5, 9).
- Significant improvement in volumes anticipated from FY27 onwards after commissioning new Egypt aseptic plant and full utilization of expanded India facility (Page 9).
- Incremental revenue from three new projects expected to be Rs. 2,000-2,500 crore at high-teens margin/full capacity (Page 13).
- Liquid packaging business expected to grow exponentially, consolidating market share in India and catering export demand through Egypt plant (Page 18).
2 more points management made on revenue & sales performance
Profitability & Margins
See what Uflex said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Remaining capex of about Rs. 110-120 crore for the recycling plant at Noida.
- Remaining capex for the BOPP Dharwad plant.
- Residual capex largely to be spent over the next 1 year; total capex around Rs. 1,200 crore for next financial year.
- Around Rs. 350 crore capex remaining post Q3 for the Egypt aseptic plant.
- Three major projects near commissioning:
- 12 billion packs expansion of aseptic liquid packaging in Egypt.
- 40,000 tons recycling plant in India near commissioning.
- 80 billion bags polypropylene woven bag plant in Mexico.
2 more points management made on capital expenditure plans
Top-ranked in Industrial Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Uflex said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Uflex — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹3.6K Cr, net profit ₹36 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Uflex Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Industrial Products this season
- Graphite India Ltd (Q3 FY26)
642 Crores, up 22.8% y-o-y (Page 9) . Key concall takeaways from Graphite India Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
- Ratnamani Metals & Tubes Ltd (Q3 FY26)
Standalone Revenue (Q3 2025-26):** ₹794.33 Crores, down from ₹1,293.53 Crores in Q3 2024-25; approximately 39% decline. Key concall takeaways from Ratnamani…
- Quadrant Future Tek Ltd (Q3 FY26)
Q3FY26 revenue from operations was ₹333 Mn, a 23.2% year-on-year (YoY) growth from ₹270 Mn in Q3FY25 (Page 31, Page 6). Key concall takeaways from Quadrant…
- Vidya Wires Ltd (Q3 FY26)
Q3 FY26 revenue from operations: ₹4,481.62 million . Key concall takeaways from Vidya Wires Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
Frequently Asked Questions
What were Uflex Q3 FY26 results?
Aseptic packaging volumes expected around 8.5 billion packs in FY26, with potential upside (Page 5, 9). - Significant improvement in volumes anticipated from FY27 onwards after commissioning new Egypt aseptic plant and full utilization of expanded India facility (Page 9). - Incremental revenue from three new projects expected to be Rs. EBITDA for FY'26 is expected to be around Rs.
What is Uflex share price analysis?
Uflex currently shows a neutral. The stock trades at a P/E of 6.4 with a market cap of ₹4,438 Cr. Investors should review the full earnings analysis for detailed insights.
Is Uflex planning capital expenditure?
Remaining capex of about Rs.
Keep Uflex on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.